Target intelligence / Profile preview

Antineoplastic

01

Overview

The term "antineoplastic" refers to a pharmacological class of agents that inhibit or prevent the growth of neoplasms (tumors), typically used as anti-cancer drugs. It is not a specific molecule, receptor, enzyme, or defined therapeutic target, but rather an umbrella term describing a wide variety of drug classes and mechanisms. Antineoplastic agents are used systemically in chemotherapy and can work through diverse mechanisms, such as damaging DNA, interfering with cell division, or modifying hormonal environments that enable cancer cell growth. This term is a therapeutic class descriptor and is not the name of a target; therefore, it cannot be mapped to a canonical target structure, molecular classification, or specific mechanism of action. For structured information on a specific antineoplastic target, the actual molecular name (e.g., "Epidermal growth factor receptor") must be provided.

Other names
anticancer agentchemotherapy drugcytotoxic agentantitumor agenthazardous drug

Beyond the preview

Go deeper on Antineoplastic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antineoplastic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call